LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Torque Therapeutics Inc.
Headquarters:
Cambridge, MA, United States
Website:
N/A
Year Founded:
2015
Status:
Merged
BioCentury
|
Oct 19, 2023
Deals
Flagship portfolio consolidation continues with Laronde-Senda
Pair of well-funded Flagship portfolio companies will unite in Sail Biomedicines to develop programmable medicines
Read More
BioCentury
|
May 19, 2022
Deals
Flagship revisits company combination strategy with Sonata
The Cygnal-Inzen mashup is taking a microenvironment-focused approach to cancer, fibrosis and autoimmunity
Read More
BioCentury
|
Apr 29, 2022
Discovery & Translation
Cleavage resistant, regulatable CARs; plus Repertoire, Merus and more
BioCentury’s roundup of translational news
Read More
BioCentury
|
Mar 5, 2022
Management Tracks
Entos builds out team with Chen as CMO, Ding as CBO
Plus Henderson becomes CEO of Wren, and updates from Bolt, argenx and more
Read More
BioCentury
|
Jul 15, 2021
Management Tracks
Freire leaving FNIH, Gottesman to leave DDIR job at NIH; plus AllianThera, Enanta, Autolus, T-Cypher, Opiant
Maria Freire will step down as president and executive director at the Foundation for the National Institute of Health in September. Freire assumed the role in 2012, making her the foundation’s
Read More
BioCentury
|
Oct 29, 2020
Product Development
Flagship’s Senda builds on Kintai’s microbe-mimicking pipeline with plant and bacteria-based delivery modalities
Emerging Company Profile: Combining four companies, Flagship builds a platform around human cells' interactions with other species
Read More
BioCentury
|
May 21, 2020
Emerging Company Profile
Repertoire bets on both sides of the TCR-antigen coin
Led by John Cox, Repertoire is mapping how TCRs, peptide-MHC complexes relate to each other, and to disease
Read More
BioCentury
|
Mar 13, 2020
Deals
Flagship’s Repertoire combines Cogen, Torque to pick antigens for immunotherapies
Read More
BioCentury
|
Oct 4, 2019
Company News
Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more
Read More
BioCentury
|
Aug 26, 2019
Company News
Management tracks: Grail, Boehringer, Torque, Bellus and Emerald
Read More
Items per page:
10
1 - 10 of 20
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help